Literature DB >> 24012117

Can statins prevent pregnancy complications?

Guillermina Girardi1.   

Abstract

Statins are potent inhibitors of cholesterol biosynthesis. The beneficial effects of the statins in preventing cardiovascular diseases are not entirely due to cholesterol reduction. Numerous studies suggest that the benefits observed with statins may be mediated by pleiotropic effects that are cholesterol-independent. There is now compelling evidence that statin therapy may diminish inflammation and oxidative stress, increase angiogenesis, inhibit the coagulation cascade and protect the endothelium. Several animal studies demonstrated that statins prevent pregnancy complications such as recurrent miscarriages and preeclampsia. Epidemiological data collected to date suggest that statins are not major teratogens. Clinical trials should be performed to demonstrate the effectiveness of statins in preventing bad pregnancy outcomes in women. Some of these trials recently started. This article summarizes the numerous effects of statins that can contribute to the pregnancy protection observed in animal models.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Pregnancy complications; Statins

Mesh:

Substances:

Year:  2013        PMID: 24012117     DOI: 10.1016/j.jri.2013.07.005

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  15 in total

Review 1.  Antiphospholipid syndrome: an update for clinicians and scientists.

Authors:  Andrew P Vreede; Paula L Bockenstedt; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

Review 2.  Mouse is the new woman? Translational research in reproductive immunology.

Authors:  David A Clark
Journal:  Semin Immunopathol       Date:  2016-01-18       Impact factor: 9.623

3.  Antepartum and postpartum changes in adipokines, endothelial dysfunction, inflammatory markers and other biochemical parameters in preeclamptic women: A prospective observational cohort study.

Authors:  Amany Yasseen Talab; Haitham Aboali Hamza; Tarek Mohamed Mostafa
Journal:  J Appl Biomed       Date:  2021-01-28       Impact factor: 1.797

4.  Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.

Authors:  Eleftheria Lefkou; Apostolos Mamopoulos; Themistoklis Dagklis; Christos Vosnakis; David Rousso; Guillermina Girardi
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

Review 5.  The effects of omega-3 fatty acids supplementation on metabolic status in pregnant women: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Elaheh Amirani; Zatollah Asemi; Omid Asbaghi; Alireza Milajerdi; Željko Reiner; Mohammad Ali Mansournia; Jamal Hallajzadeh; Bahram Moazzami; Shahla Chaichian
Journal:  J Diabetes Metab Disord       Date:  2020-06-06

Review 6.  The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia.

Authors:  Tereza Cindrova-Davies
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

Review 7.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

Review 8.  Recent advances in the prevention of preterm birth.

Authors:  Jeff A Keelan; John P Newnham
Journal:  F1000Res       Date:  2017-07-18

9.  Short- and long-term effects on reproductive parameters of female Wistar rats after exposure to rosuvastatin starting in pre-puberty.

Authors:  Jorge W F Barros; Karolina S Tonon; Cibele S Borges; Patrícia V Silva; Ana F Q Lozano; Tainá L Pacheco; Janete A Anselmo-Franci; Wilma G Kempinas
Journal:  Curr Res Toxicol       Date:  2020-11-27

10.  Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation.

Authors:  Karen Forbes; Vinit K Shah; Kirk Siddals; J Martin Gibson; John D Aplin; Melissa Westwood
Journal:  Mol Hum Reprod       Date:  2014-10-09       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.